Michael Samojla

Michael Samojla founded his career in pharmaceutical inventory management at a time when most hospitals were still relying on manual, paper-based counting systems. Over the next four decades, he would help transform the industry — introducing technology-driven approaches, building compliance frameworks, and developing the operational playbooks that IMC Pharma's clients rely on today.

As CEO and owner of IMC Pharma, Michael has guided the company through every major shift in the pharmaceutical landscape: the rise of 340B drug pricing programs, the proliferation of automated dispensing cabinets, the emergence of robotic dispensing systems, and most recently, the application of AI and real-time data analytics to inventory management. Through each transition, his focus has remained constant — helping hospital pharmacies operate with greater accuracy, lower cost, and stronger compliance.

Under his leadership, IMC Pharma has earned recognition as a nationally awarded Premier Inc vendor, a VAMC-approved supplier, and a trusted partner to more than 1,000 hospital clients across the United States. The company maintains a 99% inventory accuracy rate and delivers an average 30% cost reduction for its clients — results that reflect Michael's belief that operational excellence and financial performance are not competing priorities.

Michael writes and speaks on the topics he knows best: the future of pharmacy inventory technology, the compliance challenges facing hospital systems, and the practical strategies that separate high-performing pharmacy programs from struggling ones. His insights are grounded in real-world experience — not theory — and are aimed at the pharmacy directors, CFOs, and operations leaders who are responsible for making these decisions every day.